IP Library Granted Patent US 10,448,835
Granted Patent B2
US 10,448,835 · App. 16/239,734 · Granted Oct 22, 2019

Contactless system and method for assessing tissue viability and other hemodynamic parameters

Inventors: Michele Pierro (Westford, MA); Kyle Quinn (Fayetteville, AR); Alan Woessner (Fayetteville, AR)
Assignees: Vivonics, Inc.; The Board of Trustees of The University of Arkansas
A61B5/0071A61B5/445A61B5/14551
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,448,835
App. No.
16/239,734
Granted
Oct 22, 2019
Kind
B2
Abstract

A contactless system for assessing tissue viability and other hemodynamic parameters includes one or more light sources configured to emit lights at a predetermined wavelength sensitive to hemoglobin concentration associated with spontaneous hemodynamic oscillations at tissue in a predetermined area of a human subject. One or more polarizers are each coupled to one or more of the one or more light sources and are configured to polarize the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth and the polarized light is maintained in the polarized state at the predetermined depth. One or more detectors each including a detector polarizer coupled thereto are configured to discriminate the light maintained in the polarized state and at the predetermined depth and are configured to generate a plurality of frames of the tissue in the predetermined area at the predetermined depth. A controller is coupled to the one or more light sources and the one or more detectors. The controller is configured to: acquire the plurality of frames, select a region of interest having the same coordinates for each of the plurality of frames, average the number of pixels within each region of interest to create a raw reference signal, detrend the raw reference signal to create a detrended raw reference signal, perform frequency domain analysis of the detrended raw reference signal, identify a frequency band of interest associated with the spontaneous hemodynamic oscillations, and perform an inverse fast Fourier transform within the frequency band of interest to generate a reference signal indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation. For each sample of the reference signal at a predetermined point in time, the controller multiplies the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time. The controller adds the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue in the predetermined area.

Claims (42)

1. A contactless system for assessing tissue viability and other hemodynamic parameters, the system comprising:

one or more light sources configured to emit lights at a predetermined wavelength sensitive to hemoglobin concentration associated with spontaneous hemodynamic oscillations at tissue in a predetermined area of a human subject;

one or more polarizers each coupled to one or more of the one or more light sources configured to polarize the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth and the polarized light is maintained in the polarized state at the predetermined depth;

one or more detectors each including a detector polarizer coupled thereto configured to discriminate the light maintained in the polarized state and at the predetermined depth and configured to generate a plurality of frames of the tissue in the predetermined area at the predetermined depth; and

a controller coupled to the one or more light sources and the one or more detectors, the controller configured to:

acquire the plurality of frames,

select a region of interest having the same coordinates for each of the plurality of frames,

average the number of pixels within each region of interest to create a raw reference signal,

detrend the raw reference signal to create a detrended raw reference signal,

perform frequency domain analysis of the detrended raw reference signal,

identify a frequency band of interest associated with the spontaneous hemodynamic oscillations,

perform an inverse fast Fourier transform within the frequency band of interest to generate a reference signal indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation,

for each sample of the reference signal at a predetermined point in time, multiply the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time, and

add the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue in the predetermined area.

2. The system of claim 1 in which the spontaneous hemodynamic oscillations have a frequency in the range of 0.05 Hz to about 1.5 Hz.

3. The system of claim 1 in which the predetermined wavelength is in the range of about 500 nm to about 1,000 nm.

4. The system of claim 1 in which the predetermined depth is in the range of about 0.1 mm to about 0.5 mm.

5. The system of claim 1 in which the other hemodynamic parameters include one or more of: heart rate, resting heart rate, heart rate variability, and tissue saturation for patients suffering from diminished blood circulation.

6. The system of claim 1 in which the one or more detectors include a CCD camera.

7. The system of claim 1 in which the one or more detectors include a CMOS camera.

8. The system of claim 1 in which the predetermined area includes a burn area of the human subject.

9. The system of claim 1 in which the predetermined area includes a wound area of a human subject.

10. The system of claim 1 further including a light filtering lens coupled to one or more light sources.

11. A contactless method for assessing tissue viability and other hemodynamic parameters, the method comprising:

emitting light at a predetermined wavelength sensitive to hemoglobin concentration associated with spontaneous hemodynamic oscillations at tissue in a predetermined area of a human subject;

polarizing the light to a polarized state such that the polarized light in the polarized state diffuses into the tissue in the predetermined area at a predetermined depth and the polarized light is maintained in the polarized state at the polarized depth;

discriminating the light maintained in the polarized state and at the predetermined depth and generating a plurality of frames of the tissue in the predetermined area at the predetermined depth;

acquiring the plurality of frames;

selecting a region of interest having the same coordinates for each of the plurality of frames;

averaging the number of pixels within each region of interest to create a raw reference signal;

detrending the raw reference signal to create a detrended raw reference signal;

performing frequency domain analysis of the detrended raw reference signal;

identifying a frequency band of interest associated with the spontaneous hemodynamic oscillations;

performing an inverse fast Fourier transform within the frequency band of interest to generate a reference signal indicative of blood volume oscillations at a selected spontaneous hemodynamic oscillation;

for each sample of the reference signal at a predetermined point in time, multiplying the sample by each pixel of a frame at the same predetermined point in time to generate a three-dimensional coordinate matrix including a plurality of correlation matrix frames at each predetermined point in time; and

adding the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation to assess the viability of the tissue in the predetermined area.

12. The method of claim 11 in which adding the plurality of correlation matrix frames at each predetermined point in time to generate a two-dimensional hemodynamic map indicative of the strength of the spontaneous hemodynamic oscillation assess the viability of other hemodynamic parameters including one or more of: heart rate, resting heart rate, heart rate variability, and tissue saturation for patients suffering from diminished blood circulation.

13. The method of claim 11 in which the spontaneous hemodynamic oscillations have a frequency in the range of 0.05 Hz to about 1.5 Hz.

14. The method of claim 11 in which the predetermined wavelength is in the range of about 500 nm to about 1,000 nm.

15. The method of claim 11 in which the predetermined depth is in the range of about 0.1 mm to about 0.5 mm.

16. The method of claim 11 in which the predetermined area includes a burn area of the human subject.

17. The method of claim 11 in which the predetermined area includes a wound area of a human subject.

Assignments (3)
CONFIRMATORY LICENSE Recorded Nov 13, 2019
From: VIVONICS, INC.
To: THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY
Reel/Frame 050997/0718 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2019
From: QUINN, KYLE; WOESSNER, ALAN
To: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS
Reel/Frame 048018/0094 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2019
From: PIERRO, MICHELE
To: VIVONICS, INC.
Reel/Frame 048018/0150 →
Continuity (2)
Provisional Application 62621873 · Jan 25, 2018
Related Publication 20190223730A1 · Jul 25, 2019